New partnership with AFT Pharmaceuticals

We are delighted to announce a new partnership with AFT Pharmaceuticals, a small pharma company headquartered in Auckland, New Zealand, that is busy working in a number of areas, including topical rapamycin cream for people living with TSC.  

We’d like to thank AFT for choosing to partner with TSA (see our policy for working with pharma companies) and look forward to working together to improve the lives of everyone living with TSC. 

If your workplace, small or large, supports charities please talk to them about TSA’s work. The TSA team is ready to put forward our case for support and ideas for how they can get involved. You could be the inspiration they need to choose us as their next charity partner.

Pictured: Subir Sahai, National Hospitals Manager Australia, AFT Pharmaceuticals and Jackie Gambrell, CEO, TSA